Multimodal AI Model Predicts Breast Cancer Recurrence.
An artificial intelligence model integrating diverse tumor and patient features was retrospectively compared with a wide...
Giredestrant Delivers Long-Sought Adjuvant Benefit.
- Post category:Breast Cancer
- Reading time:1 min read
This report describes results from the phase III lidERA trial evaluating giredestrant, an oral selective estrogen recept...
Evaluating the association between upstream perceived individual and neighborhood determinants of health and intensity of breast cancer screening.
- Post category:Breast Cancer
- Reading time:1 min read
This cohort study used data from 31,568 women aged 40–74 without prior breast cancer in the All of Us Research Program...
Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer.
- Post category:Breast Cancer
- Reading time:2 mins read
This review focuses on estrogen receptor–positive early-stage breast cancer in younger premenopausal women (generally...
Implementing mainstream germline genetic testing in breast cancer across Europe.
- Post category:Breast Cancer
- Reading time:2 mins read
This publication is a narrative review focused on how to practically implement mainstream germline genetic testing for p...
The Precision Paradox: Why Modern Oncology Requires Treating Less – Selectively
- Post category:Breast Cancer/Digestive (CRC, Stomach) System/Genitourinary (Prostate, Bladder) System/Pan Cancer/Patient Communication
- Reading time:3 mins read
World Cancer Day 2026 creates a rare pause in oncology – not for awareness, but for recalibration. The theme, United by Unique, lands at a moment when the science is…